Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Regeneron Pharmaceuticals

Tracked across 9 events · 65 articles · First seen Jan 08, 2025 · Last active Jun 10, 2026

Sentiment
27
Attention
6
Events
9
Relationships
24
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Regeneron Pharmaceuticals, in collaboration with Sanofi, developed Dupixent and received regulatory approvals for new indications, which is expected to positively impact its revenue and market position.
Feb 24, 2026 · 8 articles
4 75
Business
Impact: Regeneron Pharmaceuticals, in collaboration with Sanofi, developed Dupixent and received International — European Commission approval for its use in treating chronic spontaneous urticaria in young children, which is expected to boost its market position and revenue.
Apr 13, 2026 · 8 articles
6 70
Business
Impact: Regeneron Pharmaceuticals, Inc. entered a strategic collaboration with Telix Pharmaceuticals Limited to jointly develop and commercialize next-generation radiopharmaceutical therapies, expanding its oncology portfolio and entering the targeted radiopharmaceuticals space.
Apr 12, 2026 · 6 articles
4 20
Tech
Impact: Regeneron Pharmaceuticals partly funds and supports Atara Biotherapeutics in developing therapies for diseases like inflammatory bowel disease, leveraging the Nobel-winning research.
Oct 06, 2025 · 6 articles
6 0
Regulatory
Impact: Regeneron Pharmaceuticals is expected to announce a deal with the Donald Trump administration after the holidays.
Dec 19, 2025 · 7 articles
2 10
Tech
Impact: Regeneron Pharmaceuticals is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
4 0
Business
Apr 02, 2026 · 7 articles
2 0
Tech
May 15, 2026 · 10 articles
4 0
Tech
Apr 23, 2026 · 7 articles
George Yancopoulos Regeneron Pharmaceuticals
George Yancopoulos Regeneron Pharmaceuticals
International AIDS Vaccine Initiative Regeneron Pharmaceuticals
International AIDS Vaccine Initiative Regeneron Pharmaceuticals
Mapp Biopharmaceutical Regeneron Pharmaceuticals
Serum Institute of India Regeneron Pharmaceuticals
Mapp Biopharmaceutical Regeneron Pharmaceuticals
Serum Institute of India Regeneron Pharmaceuticals
Gilead Sciences Regeneron Pharmaceuticals
Gilead Sciences Regeneron Pharmaceuticals
Merck & Co. Regeneron Pharmaceuticals
Merck & Co. Regeneron Pharmaceuticals
Uganda Regeneron Pharmaceuticals
Uganda Regeneron Pharmaceuticals
Democratic Republic of the Congo Regeneron Pharmaceuticals
Democratic Republic of the Congo Regeneron Pharmaceuticals
World Health Organization Regeneron Pharmaceuticals
World Health Organization Regeneron Pharmaceuticals
European Union Regeneron Pharmaceuticals
European Union Regeneron Pharmaceuticals
United States Regeneron Pharmaceuticals
United States Regeneron Pharmaceuticals
ERGEN INTELLIGENCE
Track Regeneron Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.